Real‐world persistence with liraglutide 3.0 mg for weight management and the SaxendaCare® patient support program

OBJECTIVE: Weight management medications can significantly increase patients' chances of achieving a clinically meaningful weight loss if patients persist with treatment. This retrospective observational study of de‐identified medical records of 311 patients is the first real‐world study examin...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Obes Sci Pract
Autors principals: Wharton, Sean, Haase, Christiane L, Kamran, Elham, Liu, Aiden, Mancini, Johanna, Neish, Drew, Pakseresht, Arash, Power, G Sarah, Christensen, Rebecca AG
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2020
Matèries:
Original Research Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7448157/
https://ncbi.nlm.nih.gov/pubmed/32874673
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/osp4.419
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars